Methocarbamol vs Tizanidine
Drug Class
Muscle relaxant
Alpha-2 adrenergic agonist
Mechanism of Action
Blocks nerve impulses (pain signals) sent to the brain. Helps relax muscles by depressing the central nervous system.
Reduces spasticity by inhibiting motor neurons at the spinal cord level.
Primary Indications
Muscle spasms, strains, sprains, and musculoskeletal pain.
Spasticity due to conditions like multiple sclerosis, spinal cord injury, or cerebral palsy.
Dosage Forms
Tablets, Injectable forms
Tablets, Capsules
Common Doses
500 mg or 750 mg tablets (3-4 times daily).
2 mg, 4 mg, or 6 mg tablets (every 6–8 hours, max: 36 mg/day).
Onset of Action
Within 30 minutes to 1 hour
1–2 hours
Duration of Effect
4–6 hours
6–8 hours
Metabolism
Liver (CYP450 enzyme system)
Liver (extensively metabolized by CYP1A2)
Half-life
1–2 hours
2.5 hours
Elimination
Primarily via urine and feces
Mostly via urine (metabolites)
Common Side Effects
Drowsiness, dizziness, headache, nausea, blurred vision.
Dry mouth, sedation, dizziness, hypotension, weakness.
Serious Side Effects
Allergic reactions, seizures (rare).
Liver injury, hallucinations, low blood pressure.
Contraindications
Severe renal impairment, hypersensitivity to Methocarbamol.
Liver disease, severe hypotension, hypersensitivity to Tizanidine.
Use in Pregnancy
Category C (risk cannot be ruled out).
Category C (risk cannot be ruled out).
Drug Interactions
CNS depressants (e.g., opioids, benzodiazepines), alcohol.
CYP1A2 inhibitors (e.g., ciprofloxacin), CNS depressants, alcohol.
Withdrawal Symptoms
Rare, but sudden discontinuation may cause mild symptoms like nausea.
Abrupt discontinuation can lead to rebound hypertension or increased spasticity.
Alcohol Interaction
Can increase dizziness and drowsiness.
Enhances the sedative effects and may lower blood pressure.
Special Populations
Elderly: Use with caution; higher risk of sedation. Renal Impairment: Dose adjustments needed.
Elderly: Higher risk of hypotension and sedation. Renal Impairment: Requires dose adjustments.
Coupon
